Washington, D.C. -- June 14, 2018 -- Measuring value in healthcare, which traditionally takes the perspective of a single payer managing population health and costs, needs to evolve to include diverse perspectives and provide relevant and actionable information on value to healthcare decision makers, according to a new article published today in the Journal [...]
The Institute for Clinical Economic Review (ICER) recently launched a new pilot program that will allow more extensive evaluation of draft economic models used in ICER's reports. In response to ICER's new program, Mark Linthicum, Director of Scientific Communications for the Innovation and Value Initiative (IVI), commented: "The Innovation and Value Initiative (IVI) is working diligently [...]
Bright Brings Decades of Health Care Experience and Established Relationships to IVI Los Angeles, CA - March 5, 2018 - The Innovation and Value Initiative (IVI) - a collaboration dedicated to developing better approaches to measuring value in health care - today announced that Jennifer Bright (pictured left), founder and President of Momentum Health [...]
Pink Sheet Senior Writer, Cathy Kelly, reports on the goals and objectives of the IVI Open-Source Value Project (OSVP), how the first iteration of the tool on rheumatoid arthritis is intended to serve different health care stakeholders, and what the next application will focus on. Kelly quotes IVI Strategic Advisory Panel Chair, Sam Nussbaum, who [...]
IVI’s “Open-Source Value Project” Develops Dynamic and Flexible Models to Help All Health Care Stakeholders Make Scientifically-Based Decisions about the Value of Treatments and Services; First Model, Released Today, is Focused on Rheumatoid Arthritis Treatments Los Angeles, CA (November 8, 2017) – The Innovation and Value Initiative (IVI) – a collaboration of academics, patient advocacy [...]
In this month's Drug Topics, correspondent Kathleen Gannon Longo speaks with Jeremy Schafer about the potentially tremendous impact that value assessments will have on future patient reimbursement decisions. Focusing on Oncology treatment, Schafer describes some of the existing value frameworks in play as well as referencing the work being done by the IVI to employ [...]
